Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $89.67 USD
Change Today +0.44 / 0.49%
Volume 211.9K
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David E. Robinson

Former Chairman, Chief Executive Officer and President, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 98 board members in 1 different organizations across 1 different industries.

See Board Relationships
65--

Background*

Mr. David E. Robinson has been the President, Chief Executive Officer and a Director of Ligand Pharmaceuticals Inc. since 1991 and Chairman of the Board Since May 1996. Mr. Robinson was Chief Operating Officer at Erbamont, a pharmaceutical company from 1987 to 1990. From 1984 to 1987, Mr. Robinson was President of Adria Laboratories, Erbamont's North American subsidiary. Before joining Erbamont he was employed in various executive positions for more than 10 years by ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

Director
1991-N/A
Former Chairman, Chief Executive Officer and President

Education*

MBA
University Of New South Wales
BA
MacQuaire University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $89.67 USD +0.44

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.